GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bone Biologics Corp (NAS:BBLGW) » Definitions » Dividend-Payout-to-FFO

Bone Biologics (Bone Biologics) Dividend-Payout-to-FFO


View and export this data going back to 2021. Start your Free Trial

What is Bone Biologics Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Bone Biologics (Bone Biologics) Business Description

Traded in Other Exchanges
Address
2 Burlington Woods Drive, Suite 100, Burlington, MA, USA, 01803
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.